Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Lancet
    January 2024
  1. KEARNEY N, Stefanovic N, Roche M
    Ultraviolet radiation manicure-related keratinocyte malignancies in a renal transplant recipient.
    Lancet. 2024;403:e1.
    >> Share

    December 2023
  2. TUTTLE KR, Hauske SJ, Canziani ME, Caramori ML, et al
    Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
    Lancet. 2023 Dec 15:S0140-6736(23)02408-X. doi: 10.1016/S0140-6736(23)02408.
    >> Share

    November 2023
  3. HEERSPINK HJL, Kiyosue A, Wheeler DC, Lin M, et al
    Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.
    Lancet. 2023 Nov 2:S0140-6736(23)02230-4. doi: 10.1016/S0140-6736(23)02230.
    >> Share

  4. ROVIN BH, Barratt J, Heerspink HJL, Alpers CE, et al
    Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
    Lancet. 2023 Nov 2:S0140-6736(23)02302-4. doi: 10.1016/S0140-6736(23)02302.
    >> Share

    August 2023
  5. HASSAN HA, Hafez MH, Luyckx VA, Tuglular S, et al
    Kidney failure in Sudan: thousands of lives at risk.
    Lancet. 2023;402:607.
    >> Share

    March 2023
  6. LUNDBERG S, Bergen K
    We can go further in non-immunosuppressive treatment of IgA nephropathy.
    Lancet. 2023 Mar 31:S0140-6736(23)00630-X. doi: 10.1016/S0140-6736(23)00630.
    >> Share

    January 2023
  7. BUDDE K, Halleck F
    Six pills less: no benefit for bicarbonate supplementation in renal allograft recipients.
    Lancet. 2023 Jan 25:S0140-6736(22)02630-7. doi: 10.1016/S0140-6736(22)02630.
    >> Share

  8. KOVALCHUK B, Khoramnia R
    Focusing on the eye signs of Alport syndrome in a 40-year-old man who previously had a kidney transplant and hearing loss.
    Lancet. 2023;401:e1.
    >> Share

    November 2022
  9. SELBY NM, Taal MW
    Evaluating the results of MyTEMP, a cluster randomised trial of lower temperature haemodialysis: the end of a cool idea?
    Lancet. 2022;400:1657-1659.
    >> Share

  10. MARK PB, Sattar N
    Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02164.
    >> Share

    September 2022
  11. FAUCON AL, Messai N, Pardon A
    A sweet unilateral pleural effusion: pleuro-peritoneal communication in a patient on dialysis.
    Lancet. 2022;400:920.
    >> Share

    January 2022
  12. TONELLI M, Thadhani R
    Anaemia in chronic kidney disease: what do new generation agents offer?
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00120.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016